tbuckley/cabot-search huggingface dataset:
Efficacy of Efanesoctocog Alfa on Physical Functioning: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A
Authors: Amanda Wilson, Nana Kragh, Jennifer Dumont, Jerome Mshijid, Annemieke Willemze, Linda Bystricka, Chuanwu Zhang, Angela C. Weyand, Kathelijn Fischer, Victor Jimenez-Yuste
Journal: Blood (2022)
Metabolic Dysfunctions Driven By <i>PRPF8</i> Explain Cases with Ring Sideroblasts without <i>SF3B1</i> Mutations: Similarity/ Differences of Genotype/ Phenotype Association
Authors: Valeria Visconte, Arda Durmaz, Hussein Awada, Ishani Nautiyal, Tariq Kewan, Waled Bahaj, Anjali Advani, Caroline Astbury, Heesun J. Rogers, Jaroslaw P. Maciejewski, Carmelo Gurnari
Journal: Blood (2022)
CD8+ TEMRA Clones Cause Platelet Lysis in Immune Thrombocytopenia
Authors: Amna Malik, Michelle MH Tan, Anwar A Sayed, Panpan Han, Eleanor Watt, Adela Constantinescu-Bercu, Ahmad Khoder, Alexander TH Cocker, Emma Thorley, Ariam Teklemichael, Yunchuan Ding, Rocel C. Saputil, Alice C J Hart, Haiyu Zhang, Wayne A. Mitchell, Nesrina Imami, James TB Crawley, Isabelle Salles-Crawley, James B. Bussel, James L Zehnder, Stuart Adams, Bing Melody Zhang, Nichola Cooper
Journal: Blood (2022)
The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab
Authors: Kimberly Guinan, Jean Lachaine, Nancy Paul Roc, Sarah-Jane Bull, Dipti Tankala, Stéphane Barakat, Christopher M. Hillis, Versha Banerji
Journal: Blood (2022)
Determinants of Survival and Retrospective Comparisons in 183 Clinical Trial Patients with Myelofibrosis Treated with Ruxolitinib, Fedratinib, Momelotinib, or BMS-911543 JAK2 Inhibitor between 2007 and 2013
Authors: Naseema Gangat, Kebede H. Begna, Aref Al-Kali, William J. Hogan, Mark R. Litzow, Animesh Pardanani, Ayalew Tefferi
Journal: Blood (2022)
Artificial Intelligence-Enhanced Models to Predict Light Chain Amyloidosis from Patients with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Authors: Eli Muchtar, Surendra Dasari, Martha Grogan, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, David Dingli, Taxiarchis Kourelis, Itzhak Z. Attia, Francisco Lopez-Jimenez, Dennis Murphree, Paul A. Friedman, Shaji K Kumar, Angela Dispenzieri
Journal: Blood (2022)
<i>Treatment-Free Remission in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib Front-Line, in Real-Life Conditions: Influence of Switching to Another TKI Prior to Cessation.</i>
Authors: Franck E. Nicolini, Vincent Alcazer, Pascale Cony-Makhoul, Stéphanie Dulucq, Sandrine Hayette, Stéphane Morisset, Rachel Parat, Christophe Bouvier, Gabriel Etienne
Journal: Blood (2022)
Similar Benefits of High-Dose Melphalan Based Conditioning Regimens Followed By Autologous Hematopoietic Cell Transplantation in Elderly Myeloma Population Compared to the Younger Group: Single Center Experience
Authors: Taiga Nishihori, Ciara L. Freeman, Doris K. Hansen, Brandon J. Blue, Omar Alexis Castaneda Puglianini, Jongphil Kim, Ariel F. Grajales-Cruz, Jason Brayer, Jose Ochoa, Hien D. Liu, Kenneth H. Shain, Rachid C. Baz, Frederick L. Locke, Melissa Alsina
Journal: Blood (2022)
Castleman's Disease:Clinicopathological Characteristics of a Cohort of Hispanic Patients
Authors: Alfonso Orozco, Daniel Montante-Montes, María José Lizardo-Thiebaud, Sergio Rodriguez-Rodriguez, Cinthya Monroy-Ramos, Berta Riveros Gilardi, Alec Seidman-Sorsby, Isabel García Carrera, José De Jesús Sandoval López, Alvaro Aguayo, Déborah Martínez-Baños
Journal: Blood (2022)
Subsequent Solid Neoplasms Following Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies: Comparing Center for International Blood and Marrow Transplant Research (CIBMTR) and California Cancer Registry (CCR) Data
Authors: Sara J. Schonfeld, Bryan Valcarcel, Christa L. Meyer, Ann M Brunson, Julianne J.P. Cooley, Renata Abrahao, Ted Wun, Jeffery Auletta, Lori Muffly, Theresa H.M. Keegan, Lindsay M. Morton
Journal: Blood (2022)
Long-Term Survival of Acute Myeloid Leukemia Responding Patients Who Stopped Azacytidine and/or Venetoclax Because of Poor Tolerance or Physician Choice: A Retrospective Multicenter Study from the French Innovative Leukemia Organization (FILO)
Authors: Sylvain Garciaz, Justine Decroocq, Sarah Bertoli, Amine Belhabri, Pierre-Yves Dumas, Celestine Simand, Kamel Laribi, Alberto Santagostino, Martin Carre, Aline Schmidt, Gaspard Aspas Requena, Chantal Himberlin, Marie-Anne Hospital, Christian Recher, Norbert Vey
Journal: Blood (2022)
Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma
Authors: Julia Driessen, Wouter J. Plattel, Lydia Visser, Anke Van Den Berg, Josée M. Zijlstra, Sanne Tonino, Gerben JC Zwezerijnen, Ronald Boellaard, Marie José Kersten, Arjan Diepstra
Journal: Blood (2022)
Complement Biomarkers for Tracking Breakthrough Hemolysis in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated with Last-Generation Complement Inhibitors
Authors: Luana Marano, Patrizia Ricci, Camilla Frieri, Eleonora Urciuoli, Ada Sanseverino, Fabiana Cacace, Ilenia Manfra, Giovanna De Santis, Selenia Vitiello, Serena Marotta, Antonio Risitano
Journal: Blood (2022)
Risk Factors Influencing Transplant Outcomes of Adults with Acute Lymphoblastic Leukemia in First Complete Remission: A Retrospective Analysis from the ALWP of the EBMT
Authors: Martina Calabrò, Myriam Labopin, Giorgia Battipaglia, Mutlu Arat, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Jan Vydra, Didier Blaise, Régis Peffault de Latour, Caroline Besley, Jean-Henri Bourhis, Renato Fanin, Nicolaus Kröger, Alessandro Rambaldi, Ben Carpenter, Péter Reményi, Tobias Gedde-Dahl, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Blood (2022)
Carfilzomib and Lenalidomide for the Treatment of Primary Plasma Cell Leukemia: Final Results of the Prospective Phase 2 EMN12/HOVON-129 Study for Patients Aged ≥66 Years
Authors: Pellegrino Musto, Monique C. Minnema, Wilfried W.H. Roeloffzen, Andrea Capra, Bronno van der Holt, Annette Juul Vangsted, Annemiek Broijl, Fredrik Schjesvold, Thomas Lund, Trine Silkjaer, Reuben Benjamin, Mariella Grasso, Ka Lung Wu, Jo Caers, Michele Cavo, Roman Hájek, Benedetto Bruno, Alain Gadisseur, Giuseppe Pietrantuono, Massimo Offidani, Luděk Pour, Pieter Sonneveld, Mario Boccadoro, Niels W.C.J. van de Donk
Journal: Blood (2022)
Interim Results of a Risk-Adaptive Phase II Study: Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (KRD-Dara) in Newly Diagnosed Multiple Myeloma (NDMM) at the Levine Cancer Institute (LCI)
Authors: Manisha Bhutani, Myra Robinson, Barry Paul, Shebli Atrash, Cindy Varga, Xhevahire Begic, David M Foureau, Mauricio Pineda-Roman, Brinda Koya, Sarah Norek, Sara A Sutton, Michelle B Anderson, Donna Acampora, James T Symanowski, Peter M. Voorhees, Saad Usmani
Journal: Blood (2022)
I-FISH Guided Cytogenetic Study of Non-Hodgkin Lymphomas in Children and Adolescents: Correlation with Etiology and Outcome
Authors: Georgia Avgerinou, Maria Filippidou, Ilona Binenbaum, Tatiana-Soultana Tziola, Kalliopi Stefanaki, Katerina Katsibardi, Dimitrios Pavlidis, Antonis Kattamis, Sophia Polychronopoulou, Marina Mantzourani, Stefanos I Papadhimitriou
Journal: Blood (2022)
VEGF and IL-6 As Markers of Severity and Response to Treatment in Waldenstrom Macroglobulinemia and IgM-Monoclonal Gammopathy of Undetermined Significance: A Monocentric Experience
Authors: Annamaria Tomasso, Idanna Innocenti, Giulia Benintende, Francesco Autore, Alberto Fresa, Florenzia Vuono, Luca Stirparo, Antonio Mosca, Claudia Giannotta, Dimitar G Efremov, Marco Luigetti, Silvia Baroni, Luca Laurenti
Journal: Blood (2022)
Interventional Antibiotic Treatment Replacing Antibiotic Prophylaxis during Allogeneic Hematopoietic Stem Cell Transplantation Is Safe and Feasible: A Single-Center Analysis
Authors: Rosa Toenges, Fabian Lang, Rakhshinda Ghaffar, Vera Schlipfenbacher, Julia Riemann, Salem Ajib, Khouloud Kouidri, Anjali Cremer, Weber Bodo, Thu Nguyen, Antje Knoch, Janne Vehreschild, Hubert Serve, Gesine Bug
Journal: Blood (2022)
Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)
Authors: Arnon P. Kater, J Christine Ye, Jose Sandoval-Sus, Mar Bellido, Jacob Haaber Christensen, Anthony R. Mato, Ann Janssens, Toshihiko Oki, Daniela Hoehn, Marcia Rios, Alexandra Kuznetsova, Rebecca Valentin, Herbert Eradat
Journal: Blood (2022)
Discontinuation of Thrombopoietin Receptor Agonists: A 10 Year Real-World Experience from an Academic Hospital in Madrid
Authors: Andres Ramirez Lopez, María Teresa Alvarez Román, María Isabel Rivas Pollmar, Mónica Martín Salces, Mar Gutierrez, Eduardo Garcia Perez, Elena G Arias-Salgado, Elena Monzón Manzano, Paula Acuña, Víctor Jiménez Yuste, Nora V. Butta, Cédric Hermans
Journal: Blood (2022)
Artificial Intelligence Methods to Estimate Overall Mortality and Non-Relapse Mortality Following Allogeneic Hematopoietic Cell Transplantation in the Modern Era: An EBMT Transplant Complications Working Party Study
Authors: Blanca Rius Sansalvador, Alberto Mussetti, Victor Moreno, Christophe Peczynski, Emmanuelle Polge, Nicolaus Kröger, Didier Blaise, Régis Peffault de Latour, Alexander D. Kulagin, Ashrafsadat Mousavi, Matthias Stelljes, Rose-Marie Hamladji, Martin Bornhäuser, Urpu Salmenniemi, Henrik Sengeloev, Edouard Forcade, Uwe Platzbecker, Péter Reményi, Emanuele Angelucci, Patrice Chevallier, Ibrahim Yakoub-Agha, Charles Craddock, Fabio Ciceri, Thomas Schroeder, Mahmoud Aljurf, Ivan Moiseev, Olaf Penack, Helene Schoemans, Mohamad Mohty, Bertram Glass, Anna Sureda, Grzegorz W Basak, Zinaida Peric
Journal: Blood (2022)
Eltrombopag Plus Diacerein Versus Eltrombopag in Adult Primary Immune Thrombocytopenia: Interim Analysis of a Multicenter, Randomized, Controlled, Phase 2 Trial
Authors: Lu Sun, Ping Qin, Ruirong Xu, Juandong Wang, Hongyu Zhao, Yan Wang, Juan Wang, Xin Wang, Yu Hou, Ming Hou
Journal: Blood (2022)
A Phase 3b, Single-Arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon Alfa-2b-Njft (P1101) in Adult Patients with Polycythemia Vera
Authors: John Mascarenhas, Oleh Zagrijtschuk, Craig Zimmerman, Albert Qin, Raymond W Urbanski
Journal: Blood (2022)
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; &amp;lt; 80 Years). IFM2020-05/Benefit
Authors: Arthur Bobin, Jerome Lambert, Aurore Perrot, Salomon Manier, Lydia Montes, Arnaud Jaccard, Lionel Karlin, Pascal Godmer, Denis Caillot, Cyrille Hulin, Thomas Chalopin, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Dingremont, Alberto Santagostino, Mamoun Dib, Margaret Macro, Mourad Tiab, Kamel Laribi, Emmanuelle Bourgeois-Petit, Claire Calmettes, Frederique Orsini, Reza Tabrizi, Laure Vincent, Mohamad Mohty, Cyrille Touzeau, Jill Corre, Philippe Moreau, Thierry Facon, Herve Avet Loiseau, Xavier Leleu
Journal: Blood (2022)
V-FAST Master Trial: Subgroup Analysis of Outcomes with CPX-351 Plus Midostaurin in Adults with Newly Diagnosed Acute Myeloid Leukemia By <i>FLT3</i> Mutation Type
Authors: James McCloskey, Vinod A. Pullarkat, Gabriel N. Mannis, Tara L. Lin, Stephen A Strickland, Amir T. Fathi, Stefan Faderl, Divya Chakravarthy, Yana Lutska, Vijayalakshmi Chandrasekaran, Ronald S. Cheung, Mark J. Levis
Journal: Blood (2022)
Healthcare Resource Utilization in Acute Myeloid Leukemia Treatments: Hypomethylating Agent + Venetoclax Vs. High Intensity Regimens
Authors: Margaret Li Krackeler, Benjamin Moskoff, Tamer Othman, Tali Azenkot, Ryan J. Beechinor, Aaron S Rosenberg, Naseem S Esteghamat, Rasmus T Hoeg, Joseph M Tuscano, Brian A. Jonas
Journal: Blood (2022)
Assesment of Patient'S Perspective on Treatment Free Remission in CML: A Turkish Multicenter Cohort
Authors: Yasa gul Mutlu, Birol Guvenc, Istemi Serin, Berrin Balik Aydin, İnci Alacacıoğlu, Serkan Guven, Omur Gokmen Sevindik
Journal: Blood (2022)
Inhibition of Lysyl Oxidases Synergizes with 5-Azacytidine to Restore Erythropoiesis in Myeloid Neoplasms
Authors: Qingyu Xu, Alexander Streuer, Johann-Christoph Jann, Eva Altrock, Nanni Schmitt, Johanna Flach, Carla Sens-Albert, Felicitas Rapp, Julia Wolf, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Ahmed Jawhar, Ali Darwich, Cleo-Aron Weis, Alexander Marx, Patrick Wuchter, Victor Costina, Evelyn Jäger, Elena Sperk, Michael Neumaier, Alice Fabarius, Georgia Metzgeroth, Florian Nolte, Laurenz Steiner, Mohamad Jawhar, Wolf-Karsten Hofmann, Vladimir Riabov, Daniel Nowak
Journal: Blood (2022)
Whole-Exome Sequencing Identifies <i>Fanc</i> Heterozygous Germline Mutation As an Adverse Factor for Immunosuppressive Therapy in Chinese Aplastic Anemia Patients Aged 40 or Younger: A Single-Center Retrospective Study
Authors: Yingying Shen, Qi Liu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Hangchao Li, Yuzhu Li, Ying Chen, Shan Liu, Qinghong Yu, Haifeng Zhuang, Zhiping Hu, Shu Deng, Jianping Shen, Shengyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu
Journal: Blood (2022)
Standard Risk-Assessment of AML Doesn't Predict the Outcome in Older AML Patients Undergoing Non-Intensive Chemotherapy
Authors: Laura Simon, Alexis Caulier, Celine Berthon, Thomas Boyer, Véronique Harrivel, Magalie Joris, Amandine Charbonnier, Etienne Paubelle, Isabelle Leduc, Nicolas Duployez, Christophe Roumier, Claude Preudhomme, Stéphane Morisset, Jean-Pierre Marolleau, Delphine Lebon
Journal: Blood (2022)
Comparable Incidence Rates of Hematologic and Non-Hematologic Malignancies, Thrombotic Events, and Autoimmune Disorders in Unrelated Adult Donors Undergoing Bone Marrow Collection Versus Peripheral Blood Stem Cell Mobilization with Recombinant Human Granulocyte Colony-Stimulating Factor (rHuG-CSF): Results of the Donor Long-Term Follow-up Study By the National Marrow Donor Program (NMDP)
Authors: Heather E Stefanski, Stephanie Bo-Subait, Hati Kobusingye, Deborah Mattila, Michelle Kuxhausen, Jennifer Schenfeld, Darcie Sandschafer, Cisio De Oliveira Brandao, Linda J Burns, Bronwen E. Shaw, Michael A. Pulsipher, John P Miller, Steven M Devine
Journal: Blood (2022)
Treatment Burden and Patient Preference in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study
Authors: Kingsley Hampton, Paul Knoebl, Jan Odgaard-Jensen, Oleksandra Stasyshyn, Jay Jay Thaung Zaw, Jesper Skov Neergaard, Bulent Zulfikar
Journal: Blood (2022)
High Karyotypic Complexity and Translocations Are Adverse Prognostic Features in Patients with Chronic Lymphocytic Leukemia without <i>TP53</i> Aberrations Treated with Venetoclax-Based Time-Limited Combinations
Authors: Moritz Furstenau, Yvonne Thus, Sandra Robrecht, Clemens Mellink, Anne-Marie Van Der Kevie-Kersemaekers, Julie M.N. Dubois, Julia Von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Mark-David Levin, Caspar Da Cunha-Bang, Christof Schneider, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse Christiansen, Michael Baumann, Thomas Noesslinger, Josien Regelink, Ellen C Dompeling, Vesa Lindström, Gunnar Juliusson, Anouk Widmer, Jeroen Simon Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna-Maria Fink, Kirsten Fischer, Clemens-Martin Wendtner, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Stephan Stilgenbauer, Eric Eldering, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Karl-Anton Kreuzer, Arnon P. Kater
Journal: Blood (2022)
International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation
Authors: Laurent Garderet, Luuk Gras, Linda Koster, Anita D'Souza, Noel Estrada-Merly, Parameswaran Hari, Wael Saber, Andrew J Cowan, Minako Iida, Shinichiro Okamoto, Hiroyuki Takamatsu, Shohei Mizuno, Koji Kawamura, Yoshihisa Kodera, Nada Hamad, Bor-Sheng Ko, Christopher Liam, Kim Wah Ho, A Sim Goh, S Keat Tan, Alaa M. Elhaddad, Ali Bazarbachi, Qamar un Nisa Chaudhry, Rozan Alfar, Mohamed-Amine Bekadja, Malek Benakli, Cristobal Augusto Frutos Ortiz, Eloisa Riva, Sebastian Galeano, Francisca Bass, Hira S Mian, Arleigh McCurdy, Feng Rong Wang, Daniel Neumann, Mickey Koh, John A Snowden, Stefan Schönland, Donal P. McLornan, Patrick John Hayden, Anna Sureda, Hildegard T. Greinix, Mahmoud Aljurf, Yoshiko Atsuta, Dietger Niederwieser
Journal: Blood (2022)
Mlkl Mediates Age-Related Attrition of Hematopoietic Stem Cells and Ineffective Hematopoiesis in Myelodysplastic Syndrome
Authors: Yuta Yamada, Masayuki Yamashita, Jinjing Yang, Shin Murai, Kenta Sumiyama, Hiroyasu Nakano, Atsushi Iwama
Journal: Blood (2022)
Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL
Authors: Karamjeet S. Sandhu, Alan Macias, Marissa Del Real, Asuscena L. Beltran, Young Sun Kim, Jianying Zhang, Joycelynne Palmer, Marjorie Robbins, Reyna Loomis, Mojtaba Akhtari, Ahmed Aribi, Shukaib Arslan, Amandeep Salhotra, Matthew Mei, Hoda Pourhassan, Paul B. Koller, Idoroenyi Amanam, Vaibhav Agrawal, Peter T. Curtin, Ricardo Spielberger, Vinod A. Pullarkat, Ibrahim Aldoss, F. Mark Stewart, Eileen P. Smith, Stephen J Forman, Anthony S. Stein, Guido Marcucci, L. Elizabeth Budde
Journal: Blood (2022)
A Second Haploidentical Stem Cell Transplantation (HAPLO-SCT2) after Relapse from First Haplo-SCT Is Feasible and Produces Results That Are Comparable to Data Reported after Second SCT in an HLA-Matched Setting - a Study on Behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Authors: Giuliano Filippini Velazquez, Myriam Labopin, Johanna Tischer, Emanuele Angelucci, Alexander D. Kulagin, Piero Galieni, Arancha Bermúdez, Claude-Eric Bulabois, Nicolaus Kröger, José Luis Díez-Martin, Arnon Nagler, Christoph Schmid, Fabio Ciceri, Mohamad Mohty
Journal: Blood (2022)
Salvage with Sequential T Cell Redirection for Myeloma Patients Who Have Previously Progressed on T Cell Directed Therapy Is Associated with Significant Cellular Activation of the Immune Microenvironment
Authors: Adolfo Aleman, Ariel Kogan Zajdman, Yogita Ghodke-Puranik, Bhaskar Upadhyaya, Tarek H. Mouhieddine, Oliver Van Oekelen, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn J. Cho, Cesar Rodriguez, Ajai Chari, Sundar Jagannath, Samir Parekh
Journal: Blood (2022)
Activin-like Kinase 2 (ALK2/ACVR1) Is a Resistance Factor and Therapeutic Vulnerability to FLT3 Inhibition in Acute Myeloid Leukemia
Authors: Anudishi Tyagi, Stanley Ly, Bin Yuan, Fouad El-Dana, Vivek Anand, Appalaraju Jaggupilli, Gautam Borthakur, Jason M Foulks, Steven L. Warner, Venkata Lokesh Battula
Journal: Blood (2022)
Unexpectedly High Prevalence of iAMP21 in Children with Acute Lymphoblastic Leukemia in Mexico: A Report from the "Mexico in Alliance with St. Jude” (MAS) Collaborative Group
Authors: Dinora Virginia Aguilar, Pablo Gonzalez-Montalvo, Hugo Romo, Daniela Arce, Nataly Mercado, Naomi Echeandia, Karla Guerrero, Margarita Gonzalez-Zamorano, Lourdes Vega, Sergio Garay, Berenice Jarquín-Ramirez, Netzi Rivera-Sanchez, Julio Moreno, Victor Ramos-Solis, Paola Friedrich
Journal: Blood (2022)
Block of Counter-Regulation By Inhibition of Protein Synthesis Sensitizes Cancer Cells to IRE1α-Mediated Apoptosis Following Unfolded Protein Response
Authors: Franziska Gsottberger, Christina Meier, Anna Ammon, Scott Parker, Kerstin Wendland, Rebekka George, Srdjan Petkovic, Lisa Mellenthin, Charlotte Emmerich, Gloria Lutzny-Geier, Markus Metzler, Andreas Mackensen, Vidyalakshmi Chandramohan, Fabian Mueller
Journal: Blood (2022)
Comparison of Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated with Venetoclax and Hypomethylating Agents Vs Other Therapies By <i>TP53</i> and <i>IDH1/2</i> Mutation: Results from the AML Real World Evidence (ARC) Initiative
Authors: Ofir Wolach, Jacqueline S. Garcia, Pinkal Desai, Pankit Vachhani, Joshua F. Zeidner, Sameem Abedin, Kendra Sweet, Catherine Lai, Yakir Moshe, Daniel A. Pollyea, Marin Xavier, Boaz Nachmias, Tsila Zuckerman, Sangmin Lee, Evan C. Chen, Srilakshmi Bathini, Wesleigh Edwards, Cat N. Bui, Wei-Han Cheng, Catherine Miller, Annie Guerin, Jessica Maitland, Esprit Ma, Melissa Montez, Moshe Grunspan, Aaron D Goldberg
Journal: Blood (2022)
Immune Checkpoint Molecules Regulate Paroxysmal Nocturnal Hemoglobinuria Clonal Evolution
Authors: Naomi Kawashima, BEN Ponvilawan, Pat Rayman, Jennifer Powers, Fauzia Ullah, Yasuo Kubota, Mai Aly, Li Lily Wang, Simona Pagliuca, Valeria Visconte, C. Marcela Diaz-Montero, Jaroslaw P. Maciejewski, Carmelo Gurnari
Journal: Blood (2022)
HLA B-Leader Mismatch Is Associated with Poor Outcomes in NIMA/NIPA Mismatched Haploidentical Sibling Donor HCT
Authors: Rohtesh S. Mehta, Rima M. Saliba, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R. Popat, Muzaffar H. Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A. Srour, Katy Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Kai Cao
Journal: Blood (2022)
Genetic and Prognostic Analysis in Blastoid and Pleomorphic Mantle Cell Lymphoma: A Multicenter Analysis in China
Authors: Ping Yang, Shuozi Liu, Chunyuan Li, Weilong Zhang, Jing Wang, Yingtong Chen, Sen Li, Cuiling Liu, Hui Liu, Qingqing Cai, Wei Zhang, Hongmei Jing
Journal: Blood (2022)
Longitudinal Profiling of the T Cell Compartment in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax
Authors: Elisavet Vlachonikola, Electra Sofou, Marina Gerousi, Efthimia Katsika, Nikolaos Pechlivanis, Georgios Karakatsoulis, Maria Dimou, Thomas Chatzikonstantinou, Michail Iskas, Panagiotis Panagiotidis, Ioanna Sakellari, Niki Stavroyianni, Kostas Stamatopoulos, Anastasia Chatzidimitriou
Journal: Blood (2022)
Pleiotropic Effects of Hydroxyurea on Red Blood Cell and Neutrophil Phenotype in Patients with Sickle Cell Disease; Data from the Notice Study
Authors: Aafke E. Gaartman, Lydian A. de Ligt, Anton T.J. Tool, Boukje M. Beuger, Martijn Veldthuis, Taco W. Kuijpers, Rob van Zwieten, Bart J. Biemond, Robin Van Bruggen, Erfan Nur
Journal: Blood (2022)
Phase II Clinical Trial of Camrelizumab Combined with AVD (Epirubicin, Vincristine and Dacarbazine) in the First-Line Treatment for Patients with Advanced Classical Hodgkin's Lymphoma
Authors: Shuang Zhao, Yanyan Liu, Zhihua Yao, Zheng Yan, Shuna Yao, Junfeng Chu, Haiying Wang, Jiuyang Zhang, Peipei Zhang, Wenping Zhou
Journal: Blood (2022)
PET-Driven Radiotherapy (RT) in Patients with Low Risk Diffuse Large B-Cell Lymphoma (DLBCL): 5-Year Results of the DLCL10 Multicenter Phase 2 Trial By Fondazione Italiana Linfomi (FIL)
Authors: Monica Balzarotti, Umberto Ricardi, Michele Spina, Andrea Evangelista, Alessandra Tucci, Federica Cavallo, Manuela Zanni, Annalisa Arcari, Vittorio Ruggero Zilioli, Roberto Sartori, Francesco Merli, Francesca Re, Umberto Vitolo, Maria Assunta Deidda, Luca Melis, Daniela Dessì, Marcello Rodari, Armando Santoro, Gianluca Gaidano, Giovannino Ciccone, Stephane Chauvie, Maria Giuseppina Cabras
Journal: Blood (2022)
Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial
Authors: Thomas Relander, Martin Bjerregård Pedersen, Fredrik Ellin, Grete Fossum Lauritzsen, Esa Jantunen, Hans Hagberg, Harald Holte, Anders Österborg, Peter De Nully Brown, Outi Kuittinen, Martin Erlanson, Bjorn Ostenstad, Unn-Merete Fagerli, Jan Delabie, Christer Sundström, Birgitta Sander, Stephen Hamilton-Dutoit, Mats Ehinger, Knut Liestol, Helle Toldbod, Andrew L. Feldman, Francesco Annibale d'Amore
Journal: Blood (2022)